Literature DB >> 25686391

Computational polypharmacology analysis of the heat shock protein 90 interactome.

Andrew Anighoro1, Dagmar Stumpfe2, Kathrin Heikamp2, Kristin Beebe3, Leonard M Neckers3, Jürgen Bajorath2, Giulio Rastelli1.   

Abstract

The design of a single drug molecule that is able to simultaneously and specifically interact with multiple biological targets is gaining major consideration in drug discovery. However, the rational design of drugs with a desired polypharmacology profile is still a challenging task, especially when these targets are distantly related or unrelated. In this work, we present a computational approach aimed at the identification of suitable target combinations for multitarget drug design within an ensemble of biologically relevant proteins. The target selection relies on the analysis of activity annotations present in molecular databases and on ligand-based virtual screening. A few target combinations were also inspected with structure-based methods to demonstrate that the identified dual-activity compounds are able to bind target combinations characterized by remote binding site similarities. Our approach was applied to the heat shock protein 90 (Hsp90) interactome, which contains several targets of key importance in cancer. Promising target combinations were identified, providing a basis for the computational design of compounds with dual activity. The approach may be used on any ensemble of proteins of interest for which known inhibitors are available.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25686391      PMCID: PMC7720080          DOI: 10.1021/ci5006959

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  58 in total

1.  Advances in the discovery and development of heat-shock protein 90 inhibitors for cancer treatment.

Authors:  Hardik J Patel; Shanu Modi; Gabriela Chiosis; Tony Taldone
Journal:  Expert Opin Drug Discov       Date:  2011-05       Impact factor: 6.098

Review 2.  Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia.

Authors:  Bryan L Roth; Douglas J Sheffler; Wesley K Kroeze
Journal:  Nat Rev Drug Discov       Date:  2004-04       Impact factor: 84.694

Review 3.  Polypharmacology: challenges and opportunities in drug discovery.

Authors:  Andrew Anighoro; Jürgen Bajorath; Giulio Rastelli
Journal:  J Med Chem       Date:  2014-06-25       Impact factor: 7.446

4.  Identifying the macromolecular targets of de novo-designed chemical entities through self-organizing map consensus.

Authors:  Daniel Reker; Tiago Rodrigues; Petra Schneider; Gisbert Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-03       Impact factor: 11.205

Review 5.  Estrogen receptor beta in breast cancer.

Authors:  C Palmieri; G J Cheng; S Saji; M Zelada-Hedman; A Wärri; Z Weihua; S Van Noorden; T Wahlstrom; R C Coombes; M Warner; J-A Gustafsson
Journal:  Endocr Relat Cancer       Date:  2002-03       Impact factor: 5.678

6.  Reactive oxygen species mediate hepatotoxicity induced by the Hsp90 inhibitor geldanamycin and its analogs.

Authors:  Yuval Samuni; Hisanari Ishii; Fuminori Hyodo; Uri Samuni; Murali C Krishna; Sara Goldstein; James B Mitchell
Journal:  Free Radic Biol Med       Date:  2010-03-06       Impact factor: 7.376

7.  Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands.

Authors:  Michael S Malamas; Eric S Manas; Robert E McDevitt; Iwan Gunawan; Zhang B Xu; Michael D Collini; Chris P Miller; Tam Dinh; Ruth A Henderson; James C Keith; Heather A Harris
Journal:  J Med Chem       Date:  2004-10-07       Impact factor: 7.446

8.  The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen.

Authors:  A K Shiau; D Barstad; P M Loria; L Cheng; P J Kushner; D A Agard; G L Greene
Journal:  Cell       Date:  1998-12-23       Impact factor: 41.582

9.  High-throughput screening fluorescence polarization assay for tumor-specific Hsp90.

Authors:  Yuhong Du; Kamalika Moulick; Anna Rodina; Julia Aguirre; Sara Felts; Raymond Dingledine; Haian Fu; Gabriela Chiosis
Journal:  J Biomol Screen       Date:  2007-10

10.  Discovery of benzisoxazoles as potent inhibitors of chaperone heat shock protein 90.

Authors:  Ariamala Gopalsamy; Mengxiao Shi; Jennifer Golas; Erik Vogan; Jaison Jacob; Mark Johnson; Frederick Lee; Ramaswamy Nilakantan; Roseann Petersen; Kristin Svenson; Rajiv Chopra; May S Tam; Yingxia Wen; John Ellingboe; Kim Arndt; Frank Boschelli
Journal:  J Med Chem       Date:  2008-01-16       Impact factor: 7.446

View more
  7 in total

1.  On the Integration of In Silico Drug Design Methods for Drug Repurposing.

Authors:  Eric March-Vila; Luca Pinzi; Noé Sturm; Annachiara Tinivella; Ola Engkvist; Hongming Chen; Giulio Rastelli
Journal:  Front Pharmacol       Date:  2017-05-23       Impact factor: 5.810

2.  An Integrated System Biology Approach Yields Drug Repositioning Candidates for the Treatment of Heart Failure.

Authors:  Guodong Yang; Aiqun Ma; Zhaohui S Qin
Journal:  Front Genet       Date:  2019-09-25       Impact factor: 4.599

3.  Multi-Targeting Bioactive Compounds Extracted from Essential Oils as Kinase Inhibitors.

Authors:  Annalisa Maruca; Delia Lanzillotta; Roberta Rocca; Antonio Lupia; Giosuè Costa; Raffaella Catalano; Federica Moraca; Eugenio Gaudio; Francesco Ortuso; Anna Artese; Francesco Trapasso; Stefano Alcaro
Journal:  Molecules       Date:  2020-05-06       Impact factor: 4.411

4.  Design and Synthesis of Hsp90 Inhibitors with B-Raf and PDHK1 Multi-Target Activity.

Authors:  Luca Pinzi; Francesca Foschi; Michael S Christodoulou; Daniele Passarella; Giulio Rastelli
Journal:  ChemistryOpen       Date:  2021-10-11       Impact factor: 2.630

Review 5.  Emerging Promise of Computational Techniques in Anti-Cancer Research: At a Glance.

Authors:  Md Mominur Rahman; Md Rezaul Islam; Firoza Rahman; Md Saidur Rahaman; Md Shajib Khan; Sayedul Abrar; Tanmay Kumar Ray; Mohammad Borhan Uddin; Most Sumaiya Khatun Kali; Kamal Dua; Mohammad Amjad Kamal; Dinesh Kumar Chellappan
Journal:  Bioengineering (Basel)       Date:  2022-07-25

6.  Computational polypharmacology comes of age.

Authors:  Giulio Rastelli; Luca Pinzi
Journal:  Front Pharmacol       Date:  2015-07-28       Impact factor: 5.810

7.  Evolution of kinase polypharmacology across HSP90 drug discovery.

Authors:  Albert A Antolin; Paul A Clarke; Ian Collins; Paul Workman; Bissan Al-Lazikani
Journal:  Cell Chem Biol       Date:  2021-06-01       Impact factor: 8.116

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.